The global Parenteral Nutrition Market size is expected to reach USD 10.7 billion by 2030 and is expected to expand at a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. Growing incidences of chronic diseases, such as cancer, diabetes, and other neurological conditions; surge in essential nutrition deficiency among critically ill patients; and growing awareness pertaining to hospital-related malnutrition are few key factors increasing the adoption of parenteral nutrition. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth. However, the high risk of infection during administration and growing preference for enteral nutrition among patients are major factors restricting the market growth.
With the increasing population, healthcare costs and
food expenditure for a household and the nation are growing. Hence, a higher
birth rate is expected to impact nutrition level, thereby acting as a driver
for the market. Realized natality plays a more prominent role than absolute
natality (crude birth rate), as it includes environmental as well as resource
pressures, such as water, food, and medication requirements per birth. Realized
natality has been growing in the last decade and is anticipated to maintain
growth over the forecast period. In 2020, the natality rate reported by the
National Center for Health Statistics (NCHS) is 11.99 births per 1,000
population. Furthermore, the percentage of lower-weight infants was 8.0%,
thereby boosting the demand for PN products worldwide.
Related Press Release@ Parenteral Nutrition Market Report
Parenteral Nutrition
Market Report Highlights
- Key players operating in the market are mainly focused on enhancing
patient safety. Companies are also focusing on advancing their PN products
to complement the parenteral nutrition compounding by incorporating
technologies, such as barcode‐assisted medication
- The ability to provide improved lipid and protein formulations to
patients is one of the key parameters that companies leverage to
differentiate their products from competitors.
- Also, high infection rate, poor water quality and sanitation
facilities, and lack of awareness are prevalent factors increasing the
incidence of malnourishment in developing nations, which creates a
significant demand for PN sources, thereby aiding market growth
- The single-dose amino acid solution nutrient type segment dominated
the market in 2021 due to the introduction of newly available amino
acid solutions with minimal side effects
- North America dominated the global market in 2021 owing to the
rising incidence of chronic conditions & malnutrition, coupled with
increasing U.S. FDA approvals in the region
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
